Abstract:DUX4 can be used as a surrogate for CIC gene rearrangements. Of 48 CIC‐rearranged sarcomas (CRS), 40 had DUX4 immunohistochemistry available and 39 had nuclear expression (sensitivity = 98%). None of the non‐CRS cases (n = 105) demonstrated this nuclear expression of DUX4 (specificity = 100%). Aims CIC‐rearranged sarcomas (CRS) are clinically aggressive undifferentiated round cell sarcomas (URCS), commonly driven by CIC::DUX4. Due to the repetitive nature of DUX4 and the variability of the fusion breakpoints, CIC::DUX4 fusion may be missed by molecular testing. Immunohistochemical (IHC) stains have been studied as surrogates for the CIC::DUX4 fusion. We aim to assess the performance of DUX4 IHC in the work‐up of CRS and its expression in non‐CRS round cell or epithelioid neoplasms. Methods and results Cases of molecularly confirmed CRS (n = 48) and non‐CRS (n = 105) were included. CRS cases consisted of 35 females and 13 males, with ages ranging from less than 1 year to 67 years (median = 41 years). Among the molecularly confirmed non‐CRS cases, C‐terminal DUX4 expression was investigated in Ewing sarcomas (38 cases), alveolar rhabdomyosarcomas (18 cases), desmoplastic small round cell tumours (12 cases) and synovial sarcomas (n = five), as well as in non‐mesenchymal neoplasms such as SMARCA4/SMARCB1‐deficient tumours (n = five), carcinomas of unknown primary (n = three) and haematolymphoid neoplasms (four cases). DUX4 IHC was considered positive when strong nuclear expression was detected in more than 50% of neoplastic cells. When used as a surrogate for the diagnosis of CRS, the sensitivity and specificity of DUX4 IHC was 98 and 100%, respectively. Only one CRS case was negative for DUX4 IHC and harboured a CIC::FOXO4 fusion. Conclusions DUX4 IHC is a highly sensitive and specific surrogate marker for the presence of CIC::DUX4 fusion, demonstrating its utility in establishing a diagnosis of CRS.

Primary Undifferentiated Sarcoma of the Kidney Harboring a Novel Variant of CIC-DUX4 Gene Fusion

Novel ATXN1/ATXN1L::NUTM2A Fusions Identified in Aggressive Infant Sarcomas with Gene Expression and Methylation Patterns Similar to CIC-rearranged Sarcoma

CIC‐DUX4 Sarcoma of the Skin: A Rare Case Report and Literature Review

Clear Cell Sarcomas of the Kidney Are Characterised by BCOR Gene Abnormalities, Including Exon 15 Internal Tandem Duplications and BCOR-CCNB3 Gene Fusion

Neoadjuvant Transcatheter Arterial Chemoembolization and Systemic Chemotherapy for Treatment of Clear Cell Sarcoma of the Kidney in Children.

Spiradenocylindroma of the kidney: clinical and genetic findings suggesting a role of somatic mutation of the CYLD1 gene in the oncogenesis of an unusual renal neoplasm.

BCOR-CCNB3 Fusion and BCOR Internal Tandem Duplication in Undifferentiated Round Cell Sarcoma: a Pathologic and Molecular Study of 5 Cases.

A Novel EPC1::KDM2B Fusion in High-grade Endometrial Stromal Sarcoma

CIC-DUX4 Chromatin Profiling Reveals New Epigenetic Dependencies and Actionable Therapeutic Targets in CIC-Rearranged Sarcomas

Clear Cell Sarcoma of Kidney Involving a Horseshoe Kidney and Harboring EGFR Internal Tandem Duplication

Clinical Relevance of BCOR Internal Tandem Duplication and TP53 Aberration in Clear Cell Sarcoma of the Kidney

DNA Methylation Profiling for Diagnosing Undifferentiated Sarcoma with Capicua Transcriptional Receptor (CIC) Alterations

Double Heterozygous Pathogenic Variants in TP53 and CHEK2 in Boy with Undifferentiated Embryonal Sarcoma of the Liver

A novel TMTC2-NTRK3 fusion in undifferentiated high-grade pleomorphic sarcoma

Spontaneous expression of the CIC::DUX4 fusion oncoprotein from a conditional allele potently drives sarcoma formation in genetically engineered mice

Malignant Progression of an Ancestral Bone Marrow Clone Harboring Acic-Nutm2afusion in Isolated Myeloid Sarcoma

Retrospective Analysis of Outcomes in Patients with Clear Cell Sarcoma of the Kidney: A Tertiary Single-Institution Experience.

Nuclear DUX4 immunohistochemistry is a highly sensitive and specific marker for the presence of CIC::DUX4 fusion in CIC‐rearranged sarcomas: a study of 48 molecularly confirmed cases

Primary Renal Synovial Cell Sarcoma In 2 Cases

A Rare Case of Renal Sarcoma Mimicking Metastatic Osteosarcoma

A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)